Furtado L

Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 70, Grand-Pré, CH-1202, Geneva, Switzerland.

2 papers · 2 preprints

ArticlePsilocybin

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.

Sabé M, Grof P, Sackett NB +24

Europe PMC2026
ArticlePsilocybin

Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.

Aboulafia-Brakha T, Buchard A, Mabilais C +11

Europe PMC2026
PreprintPsilocybin

Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland

Aboulafia-Brakha T, Buchard A, Mabilais C +11

Europe PMC2025
PreprintPsilocybin

Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement

Buchard A, Seragnoli F, Sabe M +8

Europe PMC2025